Literature DB >> 15937110

Interaction between genetic susceptibility and early-life environmental exposure determines tumor-suppressor-gene penetrance.

Jennifer D Cook1, Barbara J Davis, Sheng-Li Cai, J Carl Barrett, Claudio J Conti, Cheryl Lyn Walker.   

Abstract

Gene-environment interactions are important determinants of cancer risk. Traditionally, gene-environment interactions are thought to contribute to tumor-suppressor-gene penetrance by facilitating or inhibiting the acquisition of additional somatic mutations required for tumorigenesis. Here, we demonstrate that a distinctive type of gene-environment interaction can occur during development to enhance the penetrance of a tumor-suppressor-gene defect in the adult. Using rats carrying a germ-line defect in the tuberous sclerosis complex 2 (Tsc-2) tumor-suppressor gene predisposed to uterine leiomyomas, we show that an early-life exposure to diethylstilbestrol during development of the uterus increased tumor-suppressor-gene penetrance from 65% to >90% and tumor multiplicity and size in genetically predisposed animals, but it failed to induce tumors in wild-type rats. This exposure was shown to impart a hormonal imprint on the developing uterine myometrium, causing an increase in expression of estrogen-responsive genes before the onset of tumors. Loss of function of the normal Tsc-2 allele remained the rate-limiting event for tumorigenesis; however, tumors that developed in exposed animals displayed an enhanced proliferative response to steroid hormones relative to tumors that developed in unexposed animals. These data suggest that exposure to environmental factors during development can permanently reprogram normal physiological tissue responses and thus lead to increased tumor-suppressor-gene penetrance in genetically susceptible individuals.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15937110      PMCID: PMC1150843          DOI: 10.1073/pnas.0503218102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Penetrance of mutations in the familial Wilms tumor gene FWT1.

Authors:  N Rahman; L Arbour; R Houlston; C Bonaïti-Pellié; F Abidi; J Tranchemontagne; D Ford; S Narod; K Pritchard-Jones; W D Foulkes; C Schwartz; M R Stratton
Journal:  J Natl Cancer Inst       Date:  2000-04-19       Impact factor: 13.506

2.  Gatekeeper for endometrium: the PTEN tumor suppressor gene.

Authors:  I U Ali
Journal:  J Natl Cancer Inst       Date:  2000-06-07       Impact factor: 13.506

Review 3.  Cancer risk and low-penetrance susceptibility genes in gene-environment interactions.

Authors:  P G Shields; C C Harris
Journal:  J Clin Oncol       Date:  2000-06       Impact factor: 44.544

4.  Histologic, morphometric, and immunocytochemical analysis of myometrial development in rats and mice: I. Normal development.

Authors:  J R Brody; G R Cunha
Journal:  Am J Anat       Date:  1989-09

5.  Adenocarcinoma of the vagina. Association of maternal stilbestrol therapy with tumor appearance in young women.

Authors:  A L Herbst; H Ulfelder; D C Poskanzer
Journal:  N Engl J Med       Date:  1971-04-15       Impact factor: 91.245

Review 6.  Molecular genetic advances in tuberous sclerosis.

Authors:  J P Cheadle; M P Reeve; J R Sampson; D J Kwiatkowski
Journal:  Hum Genet       Date:  2000-08       Impact factor: 4.132

7.  Growth of mouse mammary glands after neonatal sex hormone treatment.

Authors:  Y Tomooka; H A Bern
Journal:  J Natl Cancer Inst       Date:  1982-12       Impact factor: 13.506

Review 8.  Uterine leiomyoma in the Eker rat: a unique model for important diseases of women.

Authors:  Cheryl Lyn Walker; Deborah Hunter; Jeffery I Everitt
Journal:  Genes Chromosomes Cancer       Date:  2003-12       Impact factor: 5.006

9.  Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2.

Authors:  Mary-Claire King; Joan H Marks; Jessica B Mandell
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

10.  Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.

Authors:  S Melnick; P Cole; D Anderson; A Herbst
Journal:  N Engl J Med       Date:  1987-02-26       Impact factor: 91.245

View more
  48 in total

Review 1.  Fetal and early postnatal environmental exposures and reproductive health effects in the female.

Authors:  Teresa K Woodruff; Cheryl Lyn Walker
Journal:  Fertil Steril       Date:  2008-02       Impact factor: 7.329

2.  Proceedings of the Summit on Environmental Challenges to Reproductive Health and Fertility: executive summary.

Authors:  Tracey J Woodruff; Alison Carlson; Jackie M Schwartz; Linda C Giudice
Journal:  Fertil Steril       Date:  2008-02       Impact factor: 7.329

3.  A Preliminary Study: Human Fibroid Stro-1+/CD44+ Stem Cells Isolated From Uterine Fibroids Demonstrate Decreased DNA Repair and Genomic Integrity Compared to Adjacent Myometrial Stro-1+/CD44+ Cells.

Authors:  Lauren E Prusinski Fernung; Ayman Al-Hendy; Qiwei Yang
Journal:  Reprod Sci       Date:  2018-06-28       Impact factor: 3.060

4.  Proceedings from the Third National Institutes of Health International Congress on Advances in Uterine Leiomyoma Research: comprehensive review, conference summary and future recommendations.

Authors:  James H Segars; Estella C Parrott; Joan D Nagel; Xiaoxiao Catherine Guo; Xiaohua Gao; Linda S Birnbaum; Vivian W Pinn; Darlene Dixon
Journal:  Hum Reprod Update       Date:  2014-01-08       Impact factor: 15.610

Review 5.  Phosphorylation of epigenetic "readers, writers and erasers": Implications for developmental reprogramming and the epigenetic basis for health and disease.

Authors:  Lindsey S Treviño; Quan Wang; Cheryl L Walker
Journal:  Prog Biophys Mol Biol       Date:  2015-04-02       Impact factor: 3.667

6.  The emerging spectrum of early life exposure-related inflammation and epigenetic therapy.

Authors:  Qiwei Yang; Mohamed Ali; Abdeljabar El Andaloussi; Ayman Al-Hendy
Journal:  Cancer Stud Mol Med       Date:  2018-09-17

7.  Human uterine smooth muscle and leiomyoma cells differ in their rapid 17beta-estradiol signaling: implications for proliferation.

Authors:  Erica N Nierth-Simpson; Melvenia M Martin; Tung-Chin Chiang; Lilia I Melnik; Lyndsay V Rhodes; Shannon E Muir; Matthew E Burow; John A McLachlan
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

8.  Expanding upon the Human Myometrial Stem Cell Hypothesis and the Role of Race, Hormones, Age, and Parity in a Profibroid Environment.

Authors:  Lauren E Prusinski Fernung; Kimya Jones; Aymara Mas; Daniel Kleven; Jennifer L Waller; Ayman Al-Hendy
Journal:  Am J Pathol       Date:  2018-08-01       Impact factor: 4.307

9.  Fetal onset of aberrant gene expression relevant to pulmonary carcinogenesis in lung adenocarcinoma development induced by in utero arsenic exposure.

Authors:  Jun Shen; Jie Liu; Yaxiong Xie; Bhalchandra A Diwan; Michael P Waalkes
Journal:  Toxicol Sci       Date:  2006-10-31       Impact factor: 4.849

10.  Arsenic-induced aberrant gene expression in fetal mouse primary liver-cell cultures.

Authors:  Jie Liu; Limei Yu; Erik J Tokar; Carl Bortner; Maria I Sifre; Yang Sun; Michael P Waalkes
Journal:  Ann N Y Acad Sci       Date:  2008-10       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.